Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Qidong Hepatitis B Intervention Study
NCT00222664Phase 4Completed
- Sponsor
- University of Oxford
- Start
- Sep 1983
- Modality
- Split/Subunit Vaccines, Recombinant Protein Vaccines
- Countries
- 2
01
Overview
A Phase 4 trial of Hepatitis B vaccine in hepatitis B (HBV), liver cancer, liver disease, sponsored by University of Oxford. Started Sep 1983; status: completed.
02
Drugs
Hepatitis B vaccine
03
Conditions
hepatitis B (HBV)liver cancerliver disease
Beyond the preview
Go deeper on NCT00222664.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00222664.